Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study

K. Hoffken, F. Overkamp, J. Stirbu, Axel F Grothey, M. Flasshove, D. Hoelzer, A. Ganser

Research output: Contribution to journalArticle

13 Scopus citations
Original languageEnglish (US)
Pages (from-to)33-37
Number of pages5
Issue number1
StatePublished - 1990
Externally publishedYes

ASJC Scopus subject areas

  • Oncology

Cite this